These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 32158437)
1. Global Evolution of Pathogenic Bacteria With Extensive Use of Fluoroquinolone Agents. Fuzi M; Rodriguez Baño J; Toth A Front Microbiol; 2020; 11():271. PubMed ID: 32158437 [TBL] [Abstract][Full Text] [Related]
2. Dissimilar Fitness Associated with Resistance to Fluoroquinolones Influences Clonal Dynamics of Various Multiresistant Bacteria. Fuzi M Front Microbiol; 2016; 7():1017. PubMed ID: 27458434 [TBL] [Abstract][Full Text] [Related]
3. Double-Serine Fluoroquinolone Resistance Mutations Advance Major International Clones and Lineages of Various Multi-Drug Resistant Bacteria. Fuzi M; Szabo D; Csercsik R Front Microbiol; 2017; 8():2261. PubMed ID: 29250038 [TBL] [Abstract][Full Text] [Related]
4. Has the use of fluoroquinolones facilitated the widespread dissemination of methicillin-resistant Staphylococcus aureus and extended-spectrum β-lactamase-producing Klebsiella pneumoniae in the healthcare setting? Füzi M Acta Microbiol Immunol Hung; 2014 Dec; 61(4):399-405. PubMed ID: 25361527 [TBL] [Abstract][Full Text] [Related]
5. Johnson JR; Johnston B; Thuras P; Launer B; Sokurenko EV; Miller LG mSphere; 2016; 1(6):. PubMed ID: 27904884 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of WQ-3810, a novel fluoroquinolone, against multidrug-resistant and fluoroquinolone-resistant pathogens. Kazamori D; Aoi H; Sugimoto K; Ueshima T; Amano H; Itoh K; Kuramoto Y; Yazaki A Int J Antimicrob Agents; 2014 Nov; 44(5):443-9. PubMed ID: 25239276 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of two multidrug-resistant Klebsiella species in an Indian teaching hospital and adjoining community. Rath S; Padhy RN J Infect Public Health; 2014; 7(6):496-507. PubMed ID: 24996691 [TBL] [Abstract][Full Text] [Related]
8. Emergence of an Extensively Drug-Resistant Klemm EJ; Shakoor S; Page AJ; Qamar FN; Judge K; Saeed DK; Wong VK; Dallman TJ; Nair S; Baker S; Shaheen G; Qureshi S; Yousafzai MT; Saleem MK; Hasan Z; Dougan G; Hasan R mBio; 2018 Feb; 9(1):. PubMed ID: 29463654 [TBL] [Abstract][Full Text] [Related]
10. Sequential Acquisition of Virulence and Fluoroquinolone Resistance Has Shaped the Evolution of Escherichia coli ST131. Ben Zakour NL; Alsheikh-Hussain AS; Ashcroft MM; Khanh Nhu NT; Roberts LW; Stanton-Cook M; Schembri MA; Beatson SA mBio; 2016 Apr; 7(2):e00347-16. PubMed ID: 27118589 [TBL] [Abstract][Full Text] [Related]
11. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016. Mao T; Zhai H; Duan G; Yang H Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593 [TBL] [Abstract][Full Text] [Related]
12. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants. Yang J; Luo Y; Cui S; Wang W; Han L Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956 [TBL] [Abstract][Full Text] [Related]
13. Multiple Benefits of Plasmid-Mediated Quinolone Resistance Determinants in Domokos J; Damjanova I; Kristof K; Ligeti B; Kocsis B; Szabo D Front Microbiol; 2019; 10():157. PubMed ID: 30809206 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan. Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392 [TBL] [Abstract][Full Text] [Related]
15. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016. Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099 [TBL] [Abstract][Full Text] [Related]
16. Comparative Genomic Analysis of Globally Dominant ST131 Clone with Other Epidemiologically Successful Extraintestinal Pathogenic Shaik S; Ranjan A; Tiwari SK; Hussain A; Nandanwar N; Kumar N; Jadhav S; Semmler T; Baddam R; Islam MA; Alam M; Wieler LH; Watanabe H; Ahmed N mBio; 2017 Oct; 8(5):. PubMed ID: 29066550 [No Abstract] [Full Text] [Related]
17. Whole-genome sequences of multidrug-resistant Escherichia coli in South-Kivu Province, Democratic Republic of Congo: characterization of phylogenomic changes, virulence and resistance genes. Irenge LM; Ambroise J; Bearzatto B; Durant JF; Chirimwami RB; Gala JL BMC Infect Dis; 2019 Feb; 19(1):137. PubMed ID: 30744567 [TBL] [Abstract][Full Text] [Related]
18. Commensal Fitness Advantage May Contribute to the Global Dissemination of Multidrug-Resistant Lineages of Bacteria-The Case of Uropathogenic Fuzi M; Sokurenko E Pathogens; 2023 Sep; 12(9):. PubMed ID: 37764958 [TBL] [Abstract][Full Text] [Related]
19. Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program. Pfaller MA; Acar J; Jones RN; Verhoef J; Turnidge J; Sader HS Clin Infect Dis; 2001 May; 32 Suppl 2():S156-67. PubMed ID: 11320455 [TBL] [Abstract][Full Text] [Related]
20. Phenotypic and Molecular Characterization of Antimicrobial Resistance in Klebsiella spp. Isolates from Companion Animals in Japan: Clonal Dissemination of Multidrug-Resistant Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae. Harada K; Shimizu T; Mukai Y; Kuwajima K; Sato T; Usui M; Tamura Y; Kimura Y; Miyamoto T; Tsuyuki Y; Ohki A; Kataoka Y Front Microbiol; 2016; 7():1021. PubMed ID: 27446056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]